University of Kansas Medical Center, Kansas City, KS.
University of Michigan Medical School, Ann Arbor, MI.
Chest. 2022 Oct;162(4):782-791. doi: 10.1016/j.chest.2022.05.009. Epub 2022 May 18.
Safe, effective, and easily implementable treatments that reduce the progression of respiratory failure in COVID-19 are urgently needed. Despite the increased adoption of prone positioning during the pandemic, the effectiveness of this technique on progression of respiratory failure among nonintubated patients is unclear.
What is the effectiveness of smartphone-guided self-prone positioning recommendations and instructions compared with usual care in reducing progression of respiratory failure among nonintubated patients with COVID-19?
Awake Prone Position for Early Hypoxemia in COVID-19 (APPEX-19) is a multicenter randomized clinical trial that randomized nonintubated adults with COVID-19 on < 6 L/min of supplemental oxygen to receive a smartphone-guided self-prone positioning intervention or usual care. The primary outcome was the composite of respiratory deterioration (an increase in supplemental oxygen requirement) or ICU transfer. Using a Bayesian statistical approach, the posterior probability of superiority within each treatment arm (superiority threshold 95%) was calculated.
The trial was stopped early for slow enrollment. A total of 293 participants were included in the modified intention-to-treat analysis (159 self-prone positioning intervention and 134 usual care). Among participants who self-reported body positioning (n = 139 [70 intervention, 69 usual care]), 71.4% in the intervention arm and 59.4% in the usual care arm attempted prone positioning. Thirty-one participants (posterior mean, 24.7%; 95% credible interval, 18.6-31.4) receiving usual care and 32 participants (posterior mean, 22.1%; 95% credible interval, 16.6-28.1) receiving the self-prone positioning intervention experienced the primary outcome; the posterior probability of superiority for the self-prone positioning intervention was 72.1%, less than the 95% threshold for superiority. Adverse events occurred in 26.9% of participants in the usual care arm and in 11.9% of participants in the intervention arm.
Among nonintubated patients with COVID-19, smartphone-guided self-prone positioning recommendations and instructions did not promote strong adherence to prone positioning.
ClinicalTrials.gov; No.: NCT04344587; URL: www.
gov.
目前急需安全、有效且易于实施的治疗方法,以减缓 COVID-19 患者呼吸衰竭的进展。尽管大流行期间俯卧位通气的应用有所增加,但对于未插管的患者,该技术对呼吸衰竭进展的效果尚不清楚。
智能手机指导下的自我俯卧位推荐和指导与常规护理相比,在减少 COVID-19 未插管患者呼吸衰竭进展方面的效果如何?
COVID-19 早期低氧血症仰卧位通气(APPEX-19)是一项多中心随机临床试验,纳入了接受<6L/min 补充氧气的未插管 COVID-19 成年患者,将其随机分为接受智能手机指导下的自我俯卧位干预组或常规护理组。主要结局是呼吸恶化(需要增加补充氧气需求)或转入 ICU。使用贝叶斯统计方法,计算了每个治疗组中(优势阈值 95%)优越性的后验概率。
由于入组缓慢,试验提前停止。共有 293 名参与者被纳入改良意向治疗分析(159 名自我俯卧位干预,134 名常规护理)。在自我报告体位的参与者中(n=139[70 名干预,69 名常规护理]),干预组中 71.4%和常规护理组中 59.4%尝试了俯卧位。31 名接受常规护理的参与者(后验均值,24.7%;95%可信区间,18.6-31.4)和 32 名接受自我俯卧位干预的参与者(后验均值,22.1%;95%可信区间,16.6-28.1)出现了主要结局;自我俯卧位干预的后验优势概率为 72.1%,低于 95%的优势阈值。常规护理组中 26.9%的参与者和干预组中 11.9%的参与者出现了不良事件。
在 COVID-19 未插管的患者中,智能手机指导的自我俯卧位推荐和指导并未促进患者对俯卧位的强烈依从。
ClinicalTrials.gov;编号:NCT04344587;网址:www.clinicaltrials.gov。